Summary
Cara Therapeutics Inc (Cara Therapeutics) is a biotechnology company that develops novel therapeutics for pain and inflammation and pruritus. The company offers products for therapeutic areas which include acute pain, chronic pain, neuropathic pain and pruritus. Its products include kappa receptor agonists and cannabinoid receptors. Cara Therapeutics develops analgesics g protein-coupled receptors which are class of membrane proteins, using its dimer screen technology. The company develops molecules at novel analgesic and anti-inflammatory targets using proprietary drug screening technology. It serves pharmaceutical and healthcare sectors. Cara Therapeutics is headquartered in Stamford, Connecticut, the US.
Cara Therapeutics Inc (CARA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Cara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cara Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Cara Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9
Cara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Cara Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Cara Therapeutics Enters Into Licensing Agreement With Maruishi Pharma For CR845 11
Cara Therapeutics Enters Into Licensing Agreement With Chong Kun Dang Pharma For CR845 12
Equity Offering 13
Cara Therapeutics Raises USD80.5 Million in Public Offering of Shares 13
Cara Therapeutics Completes IPO For US$63.3 Million 14
Cara Therapeutics Inc - Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19
List of Tables
Cara Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Cara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cara Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cara Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Cara Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9
Cara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Cara Therapeutics Enters Into Licensing Agreement With Maruishi Pharma For CR845 11
Cara Therapeutics Enters Into Licensing Agreement With Chong Kun Dang Pharma For CR845 12
Cara Therapeutics Raises USD80.5 Million in Public Offering of Shares 13
Cara Therapeutics Completes IPO For US$63.3 Million 14
Cara Therapeutics Inc, Key Competitors 16
Cara Therapeutics Inc, Key Employees 17
List of Figures
Cara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Cara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Cara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Cara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Cara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Cara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cara Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Cara Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9